Clinical Trials Browser

Phase 1/2 × Terminated × Medulloblastoma × Clear all

NCT03904862 2025-10-30

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

Phase 1/2 Terminated

21 enrolled

CNS

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma

NCT04167618 2023-10-06

177Lu-DTPA-Omburtamab Radioimmunotherapy for Recurrent or Refractory Medulloblastoma

Phase 1/2 Terminated

2 enrolled 9 charts

CNS

Medulloblastoma

NCT04730349 2023-03-24

PIVOT IO 020

Phase 1/2 Terminated

15 enrolled 14 charts

CNSDermatologicLymphoidOther hematologic neoplasmSarcoma

Ependymoma, Glioma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Neoplasms, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Leukemia, B-Cell

NCT01601184 2019-05-21

Study of Vismodegib in Combination With Temozolomide Versus Temozolomide Alone in Patients With Medulloblastomas With an Activation of the Sonic Hedgehog Pathway

Phase 1/2 Terminated

24 enrolled

CNS

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma

NCT02332889 2018-05-04

Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETs

Phase 1/2 Terminated

1 enrolled 6 charts

CNS

Glioma, Medulloblastoma, Neuroectodermal Tumors, Primitive